Signal transduction of physiological concentrations of vasopressin in A7r5 vascular smooth muscle cells -: A role for PYK2 and tyrosine phosphorylation of K+ channels in the stimulation of Ca2+ spiking

Signal transduction of physiological concentrations of vasopressin in A7r5 vascular smooth muscle cells -: A role for PYK2 and tyrosine phosphorylation of K+ channels in the stimulation of Ca2+ spiking
复制标题

DOI:
10.1074/jbc.m104726200
复制
发表时间:
2002-03-01
影响因子:
4.8
通讯作者:
Lucchesi, PA
Lucchesi, PA
中科院分区:
生物学2区
文献类型:
--
作者:
Byron, KL;Lucchesi, PA

文献摘要

被引文献

相似文献

在A7r5血管平滑肌细胞的融合培养中,研究了连接[Arg(8)]血管加压素(AVP)生理浓度与Ca2+尖峰频率增加的信号转导途径。免疫沉淀/Western blot研究显示,在A7r5细胞中,4 - β -phorbol 12-肉豆汁酸13-醋酸酯或离子霉素处理后,非受体酪氨酸激酶PYK2的酪氨酸磷酸化显著增加。100pm AVP还能诱导PYK2酪氨酸磷酸化,蛋白激酶C抑制剂Ro-31-8220 (1-10 muM)或chelerythrine chloride (1-20 muM)能抑制这一作用。在载fura-2的A7r5细胞中,100 pM AVP或1 nM 4β -phorbol 12-肉豆酸酯13-醋酸酯对Ca2+峰值的刺激被PP2 (10 muM, Src家族激酶抑制剂)完全阻断。水杨酸盐(20毫米,最近确定为PYK2抑制剂)和酪氨酸激酶抑制剂tyrphostin A47 (50 muM),但不是其无活性类似物tyrphostin A63,也阻断avp刺激的Ca2+尖峰。PP2和水杨酸均能抑制PYK2的磷酸化,而tyrphostin A47不能抑制PYK2酪氨酸的磷酸化。ERK1/2激酶似乎没有参与,因为1)100 pm AVP没有明显增加ERK1/2磷酸化,U-0126 (2.5 muM)没有抑制AVP刺激的Ca2+峰值;2)表皮生长因子(10 nM)强烈刺激ERK1/2磷酸化,但不诱导Ca2+峰值。延迟整流K+通道可能介导PYK2活性,因为Kv1.2通道蛋白与PYK2共免疫沉淀,Kv1.2的酪氨酸磷酸化被AVP刺激,被Ro-31-8220、PP2和水杨酸盐抑制,但不被tyrphostin A47抑制。我们的发现与PYK2和K+通道磷酸化在AVP生理浓度刺激Ca2+尖峰中的作用是一致的。
The signal transduction pathway linking physiological concentrations of [Arg(8)]vasopressin (AVP) to an increase in frequency of Ca2+ spiking was examined in confluent cultures of A7r5 vascular smooth muscle cells. Immunoprecipitation/Western blot studies revealed a robust increase in tyrosine phosphorylation of the nonreceptor tyrosine kinase, PYK2, in A7r5 cells treated with 4beta-phorbol 12-myristate 13-acetate or ionomycin. 100 pm AVP also induced PYK2 tyrosine phosphorylation, and this effect was inhibited by protein kinase C inhibitors Ro-31-8220 (1-10 muM) or chelerythrine chloride (1-20 muM). In fura-2-loaded A7r5 cells, the stimulation of Ca2+ spiking by 100 pM AVP or 1 nM 4beta-phorbol 12-myristate 13-acetate was completely blocked by PP2 (10 muM, a Src family kinase inhibitor). Salicylate (20 mm, recently identified as a PYK2 inhibitor) and the tyrosine kinase inhibitor, tyrphostin A47 (50 muM), but not its inactive analog, tyrphostin A63, also blocked AVP-stimulated Ca2+ spiking. PYK2 phosphorylation was inhibited by both PP2 and salicylate, whereas tyrphostin A47 failed to inhibit PYK2 tyrosine phosphorylation. ERK1/2 kinases did not appear to be involved because 1) 100 pm AVP did not appreciably increase ERK1/2 phosphorylation and U-0126 (2.5 muM) did not inhibit AVP-stimulated Ca2+ spiking; and 2) epidermal growth factor (10 nM) robustly stimulated ERK1/2 phosphorylation but did not induce Ca2+ spiking. Delayed rectifier K+ channels may mediate the PYK2 activity because Kv1.2 channel protein co-immunoprecipitated with PYK2 and tyrosine phosphorylation of Kv1.2 was stimulated by AVP and inhibited by Ro-31-8220, PP2, and salicylate but not tyrphostin A47. Our findings are consistent with a role for PYK2 and phosphorylation of K+ channels in the stimulation of Ca2+ spiking by physiological concentrations of AVP.